| HR | CI 95% | P value |
---|---|---|---|
Univariate analysis | |||
Initial PS | 0.86 | 0.37–1.97 | 0.72 |
Primary | Â | Â | Â |
 Kidney vs lung |  |  |  |
 Other vs lung |  |  |  |
Extracranial metastasis at diagnosis | Â | Â | 0.54 |
No | 1 | Â | Â |
Yes | 1.31 | 0.54–3.19 |  |
Brain metastasis as first sign of cancer | Â | Â | Â |
No | Â | Â | 0.37 |
Yes | 1 | Â | Â |
 | 1.44 | 0.63–3.29 |  |
Number of initial brain metastases | 1.44 | 0.93–2.23 | 0.09 |
Previous GK treatment | 1.13 | 0.26–4.94 | 0.86 |
Previous WBRT treatment | 0.53 | 0.07–4.05 | 0.54 |
BSBM | 0.78 | 0.50–1.22 | 0.28 |
GPA | 0.59 | 0.34–1.03 | 0.06 |
RPA | 0.99 | 0.37–2.62 | 0.98 |
Age at time of treatment | 0.99 | 0.94–1.03 | 0.73 |
Subtentorial location | 1 | Â | 0.23 |
Supratentorial location | 1.76 | 0.69–4.48 |  |
Size of preoperative lesion | 1.63 | 0.51–5.14 | 0.4 |
Time between surgery-GK | 0.99 | 0.97–1.00 | 0.32 |
Volume lesion treated with GK | 0.91 | 0.83–1.01 | 0.09 |
Dose GK treatment | 1.12 | 0.94–1.33 | 0.19 |
Other existing lesions treated at the same time with GK | Â | Â | Â |
 | 1.16 | 1.005–1.34 | 0.04 |
Multivariate analysis taking variables with p < 0.2 in univariate analysis + use of Increasing automatic selection technique | |||
Primary lesions | Â | Â | Â |
 Kidney vs lung | 1.04 | 0.23–4.69 | 0.95 |
 Other vs lung | 8.04 | 1.82–35.4 | 0.006 |
Other existing lesions treated at the same time with GK | 1.17 | 1.00–1.37 | 0.05 |